Mucomyst (Acetylcysteine)

Mucomyst is a mucolytic agent that works on respiratory secretions and toxic acetaminophen metabolism.

• Chronic obstructive pulmonary disease (COPD): improves clearance of viscous sputum and eases breathing.
• Bronchiectasis: reduces sputum thickness, facilitating expectoration.
• Acetaminophen (paracetamol) overdose: provides an antidotal effect by replenishing glutathione stores and enhancing detoxification.

• Acetylcysteine cleaves disulfide bonds within mucus glycoproteins, lowering viscosity and promoting mucociliary clearance. It also serves as a precursor for intracellular glutathione synthesis, helping to neutralize the toxic metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI) formed during acetaminophen overdose, thereby protecting hepatic cells.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Vomiting: occasional emesis after oral intake.
• Diarrhea: loose stools may occur.
• Abdominal discomfort: cramping or pain.
• Rash: skin redness or itching.
• Headache: transient head pain.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with breathing difficulty.
• Severe bronchospasm: sudden narrowing of airways.
• Angioedema: swelling of face, lips, or tongue.
• Hepatic dysfunction: abnormal liver enzymes.
• Neutropenia: low white blood cell count.
• Stevens‑Johnson syndrome: rare severe skin reaction.

Before initiating therapy, consider patient‑specific factors and handling requirements.

• Assess renal function: adjust use in severe renal impairment.
• Monitor for bronchospasm: avoid in patients with active asthma.
• Avoid in known hypersensitivity: discontinue if allergic signs appear.
• Caution in pregnancy: use only if benefit outweighs potential risk.
• Avoid concomitant nitroglycerin: may cause marked hypotension.
• Store at ambient temperature below 25°C: keep in original pack, protect from moisture.

Acetylcysteine may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Nitroglycerin: can precipitate severe hypotension.
• Activated charcoal: reduces acetylcysteine absorption if given simultaneously.
• Anticholinergic agents: may blunt mucolytic effectiveness.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR, monitor coagulation.
• Bronchodilators: watch for additive bronchospasm.
• Other mucolytics: increased risk of gastrointestinal upset.